PremiumThe FlyMarsh McLennan price target lowered to $238 from $264 at BofA Balanced Outlook for Marsh & McLennan: Hold Rating Amid Mixed Performance Indicators Balanced Outlook on Marsh & McLennan: Hold Rating Amid Growth and Cost Challenges PremiumThe FlyMarsh McLennan reports Q1 adjusted EPS $3.06, consensus $3.00 MMC Earnings Report this Week: Is It a Buy, Ahead of Earnings? Marsh McLennan price target raised to $244 from $237 at Jefferies PremiumThe FlyMarsh McLennan initiated with a Buy at Redburn Atlantic Marsh McLennan’s Mercer to acquire SECOR Asset Management; terms not disclosed Marsh & McLennan’s Healthcare Challenges: Navigating Regulatory Risks and Reputation Concerns 
